Cervarix® is the vaccine chosen by the Government for its programme, launched in September 2008, to, vaccinate girls aged 12–13 and 17–18 against HPV.
It is encouraging that Cervarix® is found to generate a good immunogenic response but it is important to recognise that these results do not mean that Gardasil® is inferior to Cervarix® in protecting women against cervical cancer. The minimum effective antibody level is not known. In addition, Gardasil ® also protects against HPV 6 and 11, the viruses that cause genital warts. While these warts do no cause cancer, they can be a source of distress and disfigurement.
It will take several years before clinically applicable comparative data between the two vaccines become available but the important thing in the mean time is for eligible women to accept the vaccine, lead a healthy lifestyle and attend for screening when invited.
This type of cancer constitutes the highest killer among other cancers. This cancer affects the women's cervix, this means that, it can only occur to the women. Interestingly enough, it is the most preventatable of all types of cancer. This is why women are advised to go for regular chech-up, such as PAP TEST.
The early detection of this condition can be treated with chemotherapy and at severe stages, it may also require radiotherapy to heat up and kill the cells. Even though, the late detection can lead to relapse.